Bria-OTS has cleared its safety evaluation in the Phase 1/2 study monotherapy dosage settingPhase 1/2 study has now transitioned to dosing patients in combination with checkpoint inhibitor in ...

As shown in table 2, both OS and CBR values were in line or higher than those reported in the treatment arm of the ASCENT ...

Bria-OTS, a personalized next-generation version of Bria-IMT™—currently in a pivotal Phase 3 trial—is designed to enhance immune responses against tumors. The CPI combination cohort follows ...

Yet its flagship financial vehicle, the Turkic Investment Fund (TIF), has stalled. Launched with $500 million in capital – ...

Takeover ANDRITZ to acquire Diamond Power International 05.06.2025 / 12:57 CET/CEST The issuer is solely responsible for the content of this announcement.

It took more than 114 minutes, but there finally is some separation between the McCann Tech and Lenox boys lacrosse teams.

Bria-OTS has cleared its safety evaluation in the Phase 1/2 study monotherapy dosage settingPhase 1/2 study has now ...

Annual Results voestalpine AG: voestalpine generates solid result in the 2024/25 business year despite difficult environment 04.06.2025 / 07:30 CET/CEST The issuer is solely responsible for the ...

On Monday, BriaCell Therapeutics Corp. (NASDAQ: BCTX) announced robust overall survival and clinical benefit data from its ...

PHILADELPHIA - It often gets lost after two $60 million contract extensions, a second-team All-Pro berth, and being graded by Pro Football Focus as the best pla ...

As the global economic landscape becomes increasingly interconnected, regional alliances are playing a more prominent role in ...